NCOA2 and neoplasm: All three cuSCC cell lines demonstrated enhanced in vivo tumor growth with KMT2C or NCOA2 depletion compared to cells with a non-targeting control shRNA (Fig 9G and 9H and 9I, 1-factor ANOVA, q<0.05).